408 related articles for article (PubMed ID: 3083832)
1. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
Kukita H; Hamada M; Hiwada K; Kokubu T
Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.
Ford ES; Cooper RS; Simmons B; Castaner A
J Clin Epidemiol; 1990; 43(5):425-32. PubMed ID: 2109048
[TBL] [Abstract][Full Text] [Related]
4. Discriminative value of lipids and apoproteins in coronary heart disease.
De Backer G; Rosseneu M; Deslypere JP
Atherosclerosis; 1982 Apr; 42(2-3):197-203. PubMed ID: 6803813
[TBL] [Abstract][Full Text] [Related]
5. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
Kukita H; Hiwada K; Kokubu T
Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307
[TBL] [Abstract][Full Text] [Related]
6. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men.
Hämäläinen E; Adlercreutz H; Ehnholm C; Puska P
Metabolism; 1986 Jun; 35(6):535-41. PubMed ID: 3086660
[TBL] [Abstract][Full Text] [Related]
7. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
Marcovina S; Zoppo A; Graziani MS; Vassanelli C; Catapano AL
Ric Clin Lab; 1988; 18(4):319-28. PubMed ID: 3150125
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships.
Mendoza SG; Zerpa A; Velazquez E; Schwarzenberg A; Hynd B; Kashyap ML; Laskarzewski P; Glueck CJ
Int J Obes; 1986; 10(6):427-41. PubMed ID: 3100468
[TBL] [Abstract][Full Text] [Related]
11. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
Shima K; Tanaka A; Ejiri N; Maezawa H
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of lipids and apolipoproteins in angiographically assessed coronary artery disease in Japanese patients.
Sawada Y; Kotake H; Hoshio A; Ogino K; Nawada T; Hisatome I; Fujimoto Y; Mashiba H
J Med; 1992; 23(6):433-42. PubMed ID: 1293253
[TBL] [Abstract][Full Text] [Related]
15. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
Nieminen MS; Mattila KJ; Aalto-Setälä K; Kuusi T; Kontula K; Kauppinen-Mäkelin R; Ehnholm C; Jauhiainen M; Valle M; Taskinen MR
Arterioscler Thromb; 1992 Jan; 12(1):58-69. PubMed ID: 1346250
[TBL] [Abstract][Full Text] [Related]
16. Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
Al-Muhtaseb N; Hayat N; Al-Khafaji M
Atherosclerosis; 1989 Jun; 77(2-3):131-8. PubMed ID: 2751745
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
Stuyt PM; Brenninkmeijer BJ; Demacker PN; Hendriks JC; van Elteren P; Stalenhoef AF; van 't Laar A
Scand J Clin Lab Invest; 1991 Sep; 51(5):425-35. PubMed ID: 1947727
[TBL] [Abstract][Full Text] [Related]
18. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
Hamsten A; Walldius G; Dahlén G; Johansson B; De Faire U
Atherosclerosis; 1986 Feb; 59(2):223-35. PubMed ID: 3083833
[TBL] [Abstract][Full Text] [Related]
19. LDL molecular size as risk factor in coronary artery disease.
Kozma L; Fodor J; Chockalingam A; Sussex B
Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
